Skip to main content
NCBI home page
Antimicrobial Resistance and Infection Control logoLink to Antimicrobial Resistance and Infection Control
. 2019 Jan 11;8:11. doi: 10.1186/s13756-019-0462-1

Correction to: Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study

Sijun Pan 1,2,#, Xiaofang Huang 1,#, Yesong Wang 1,#, Li Li 3, Changyun Zhao 3, Zhongxiang Yao 2, Wei Cui 1, Gensheng Zhang 1,✉
PMCID: PMC6330455  PMID: 30651977

Correction to: Antimicrob Resist Infect Control

https://doi.org/10.1186/s13756-018-0305-5

The original article [1] contains an error in the Safety analysis sub-section of the results regarding the reported mean creatinine level. The correct mean creatinine level was 42.09 ± 18.54 μmol/L at 48 hours after polymyxin B injection instead of the reported 41.09 ± 11.46 μmol/L.

Reference

  • 1.Pan S, et al. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study. Antimicrob Resist Infect Control. 2018;7:8. doi: 10.1186/s13756-018-0305-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Resistance and Infection Control are provided here courtesy of BMC

RESOURCES